Abstract
Objective
To describe the use of inhaled aerosolized prostacyclin (IAP) in a patient with life-threatening pulmonary hypertension secondary to pulmonary embolism and to discuss the possible use of inhaled prostacyclin in the management of pulmonary embolism.
Design
Case report.
Setting
Intensive care unit of a university teaching hospital.
Patients
One patient with severe pulmonary hypertension secondary to acute-on-chronic pulmonary embolism.
Interventions
Conventional medical management of massive pulmonary embolism and inhaled aerosolized prostacyclin (IAP).
Measurements and results
Description of clinical course, haemodynamic data and gas exchange data.
Conclusions
We describe a patient with massive pulmonary embolism for whom the addition of IAP to his therapy appeared to result in a transient improvement in pulmonary haemodynamics and gas exchange.
Article PDF
References
Jones DK, Higgenbottom TWJ, Wallwork J (1987) Treatment of primary pulmonary hypertension with intravenous epoprostenol (prostacyclin). Br Heart J 57:270–278
Rubin CJ, Mendoza J, Hood M, McGown M, Barst R, Williams WB, Diehl JH, Crow J, Lang W (1990) Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomised trial. Ann Intern Med 112:485–491
Walmrath D, Scheider T, Pilch J, Grimminger F, Seeger W (1993) Aerosolised prostacyclin in adult respiratory distress syndrom. Lancet 342:961–962
McKintyre KM, Sasahara AA (1971) The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease. Am J Cardiol 28:288–294
Welte M, Zwissler B, Habazettl H, Messmer K (1993) PGI2 Aerosol versus nitric oxide for selective pulmonary vasodilatation in hypoxic pulmonary vasoconstriction. Eur Surg Res 25: 329–340
Frostell C, Fratocci MD, Wain JC, Jones R, Zapol WM (1991) Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83:2038–2047
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Webb, S.A.R., Stott, S. & van Heerden, P.V. The use of inhaled aerosolized prostacyclin (IAP) in the treatment of pulmonary hypertension secondary to pulmonary embolism. Intensive Care Med 22, 353–355 (1996). https://doi.org/10.1007/BF01700458
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01700458